Bellerophon Therapeutics
BLPH
#11323
Rank
S$0.18 M
Marketcap
S$0.01547
Share price
-36.84%
Change (1 day)
-80.15%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): S-$1.19

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$1.08. In 2017 the company made an earnings per share (EPS) of S-$26.68 an increase over its 2016 EPS that were of S-$30.93.

EPS history for Bellerophon Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$1.19
2017S-$26.68-13.75%
2016S-$30.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
S$3.49-421.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$1.82 67.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Lantheus Holdings
LNTH
S$5.34-592.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
S$1.70-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA